(Q37845424)

24 August 2017

1 reference

title

Vancomycin dosing in patients on intermittent hemodialysis (English)

1 reference

24 August 2017

1 reference

1 reference

Stefaan J Vandecasteele

series ordinal

1

1 reference

24 August 2017

An S De Vriese

series ordinal

2

1 reference

24 August 2017

publication date

1 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

24

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

50-55

1 reference

Clinical pharmacokinetics of vancomycin

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Recent changes in vancomycin use in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

The pharmacokinetic and pharmacodynamic properties of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

21 January 2018

Vancomycin: a history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Vascular access-related infections: definitions, incidence rates, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Vancomycin use in patients requiring hemodialysis: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Assessment of vancomycin use in chronic haemodialysis patients: room for improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Clinical review: use of vancomycin in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Pharmacokinetics of vancomycin in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Vancomycin ototoxicity: a reevaluation in an era of increasing doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Vancomycin pharmacokinetics in normal and morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

Drug dosing considerations in alternative hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2010.00803.X

10.1111/J.1525-139X.2010.00803.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference